Casdin Capital, LLC Voyager Therapeutics, Inc. Transaction History

Casdin Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$10.01 - $13.75 $7.51 Million - $10.3 Million	-750,000 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$8.05 - $14.21 $2.78 Million - $4.9 Million	-345,075 Reduced 31.51%	750,000 $9.47 Million
Q4 2019 Feb 14, 2020	SELL	$12.82 - $16.85 $423,060 - $556,050	-33,000 Reduced 2.93%	1,095,075 $15.3 Million
Q4 2018 Feb 13, 2019	SELL	$8.59 - $18.05 $59,485 - $124,996	-6,925 Reduced 0.61%	1,128,075 $10.6 Million
Q4 2017 Feb 14, 2018	BUY	$12.26 - $25.88 $3.92 Million - $8.28 Million	320,000 Added 39.26%	1,135,000 $18.8 Million
Q3 2017 Nov 14, 2017	BUY	$8.37 - $20.59 $6.82 Million - $16.8 Million	815,000	815,000 $16.8 Million

128

36.7M

48K

36.2K

Ticker VYGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,647,600
Market Cap $226M
Description
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...

Get notified when there are updates to the investment portfolio of Casdin Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Casdin Capital, LLC with notifications on news.